Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MOLN Molecular > Detailed Quotes

MOLN Molecular

Watchlist
6.450
-0.160-2.42%
Trading Session  01/31 12:15 ET
High
6.460
Open
6.330
Turnover
17.06K
Low
6.330
Pre Close
6.610
Volume
2.65K
Market Cap
209.73M
P/E(TTM)
1.69
52wk High
27.190
Shares
32.51M
P/E(Static)
Loss
52wk Low
5.500
Float Cap
115.80M
Bid/Ask %
-11.11%
Historical High
32.040
Shs Float
17.95M
Volume Ratio
2.37
Historical Low
5.500
Dividend TTM
--
Div Yield TTM
--
P/B
0.85
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.02%
Amplitude
1.97%
Avg Price
6.434
Lot Size
1
Float Cap
115.80M
Bid/Ask %
-11.11%
Historical High
32.040
Shs Float
17.95M
Volume Ratio
2.37
Historical Low
5.500
Dividend TTM
--
P/B
0.85
Dividend LFY
--
Turnover Ratio
0.02%
Amplitude
1.97%
Avg Price
6.434
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274 and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.
CEO: Dr. Patrick Amstutz, PhD
Market: NASDAQ
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist